ArticleFrontiers in oncology2022

Identification and validation of an immunological microenvironment signature and prediction model for epstein-barr virus positive lymphoma: Implications for immunotherapy.

Chenjiao Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.